Vasowatch Secured Funding for Hemorrhage Detection Tech
The Philadelphia-based startup received $250,000 to advance its postpartum hemorrhage prediction system.
Updated on Sept. 30, 2026 in Pregnancy
Live Poll
Should hospitals prioritize medical technologies designed for existing equipment to lower healthcare costs?
Vasowatch has received a $250,000 investment from the University of Pennsylvania's $10 million StartUP Fund. The company is developing a patented algorithm that analyzes heart rate data to identify postpartum hemorrhage risk in real time.
Why it matters
The technology aims to curb the 43,000 annual global deaths attributed to postpartum hemorrhage by enabling earlier medical intervention. By integrating with existing hospital monitoring hardware, the system seeks to address the delayed recognition of dangerous blood loss.
Vasowatch received $250,000 from the University of Pennsylvania's $10 million StartUP Fund to develop its heart-rate monitoring software. The company also secured funding from the SWAN Impact Network.
The players
Vasowatch
This Philadelphia-based medical technology company is developing diagnostic tools to detect postpartum hemorrhage.
University of Pennsylvania
This institution manages a $10 million StartUP Fund designed to support emerging businesses and research initiatives.
SWAN Impact Network
This organization provides early-stage capital and support to companies focused on social and environmental impact.
The details
Vasowatch, headquartered in Philadelphia, has created a system that monitors existing hospital devices for physiological indicators of hemorrhage. The software is designed to alert medical staff to potential crises more rapidly than current observational standards.
Timeline
A pivotal clinical trial is scheduled to begin in January 2027.
The company targets FDA authorization for its algorithm in mid-2028.
Culture Shift
This investment highlights a growing focus on maternal health technology, a sector historically underfunded compared to other medical domains. The push toward digital predictive diagnostics reflects a broader societal movement to leverage machine learning to close gaps in obstetric care.
The development of this software could eventually standardize safer monitoring protocols for patients giving birth at local institutions like the Pennsylvania Hospital. Residents should note that the technology remains in the investigational phase and is not yet available for clinical use.
The takeaway
Predictive algorithms in the delivery room represent a significant shift toward proactive obstetric care. Patients should discuss existing hemorrhage monitoring protocols with their healthcare providers during prenatal appointments.
Further reading
For more on the latest advancements in maternal health, visit the /lifestyle/family/pregnancy/ section.
Source note: This article includes information reported by Technical.
Live Poll
Should hospitals prioritize medical technologies designed for existing equipment to lower healthcare costs?
